A twice-yearly injection of Lenacapavir offers a 96% reduced risk of infection overall, making the injection significantly more effective than the daily oral PrEP...
Kidney transplantation between donors and recipients with HIV was safe and noninferior to transplantation from donors without HIV. These findings offer evidence to support...
Telehealth could be a viable long-term option for people living with HIV (PLHIV), potentially saving them time, effort and expense related to in-person medical...
Gilead Sciences signed licensing agreements with six generic manufacturers to increase access to lenacapavir for HIV prevention. But no, it will still not be...